Sales Development Representative
Ampersand
Summary
Ampersand is hiring Sales Development Representatives to build the top of the sales funnel from the ground up. You'll find and engage the right companies, start conversations with technical buyers, and book qualified meetings for the Founding AEs, working closely with Ampersand's GTM leadership. This is a role for someone hungry to learn how a startup's sales engine gets built, and who wants to grow with it.
Job description
The Role
Ampersand is hiring Sales Development Representatives to build the top of the sales funnel from the ground up. You'll find and engage the right companies, start conversations with technical buyers, and book qualified meetings for the Founding AEs, working closely with Ampersand's GTM leadership. This is a role for someone hungry to learn how a startup's sales engine gets built, and who wants to grow with it.
What You'll Own
- Outbound prospecting: research target accounts and reach out through email, LinkedIn, and calls to start conversations with engineering and product leaders
- Qualification: run first conversations that uncover real integration needs and qualify opportunities against Ampersand's ideal customer profile
- Booking and handoff: book meetings for the Founding AE, and hand them off with clear context so deals start strong
- Pipeline discipline: track your activity and pipeline carefully, and learn what's working
- Playbook building: help shape messaging, sequences, and objection handling, since you'll be helping write the playbook, not just follow it
- Learning the product: build enough understanding of APIs, integrations, and AI agents to have credible conversations with technical buyers
What You'll Bring
- 1+ years as an SDR or BDR in B2B SaaS
- A record of hitting or exceeding your meeting or pipeline targets, ideally ranking near the top of your team
- AI fluency: you use AI tools in your daily work
- Technical curiosity: you don't need to be an engineer, but you're excited to learn the basics of APIs, webhooks, and integrations
- Strong writing and communication, especially in cold outreach
- A builder's mindset: you thrive in ambiguity and want to help design the process
Even better if you
- Have prospected into technical buyers (engineering or product leaders)
- Have used tools like Clay or sales engagement platforms
- Have a technical background: computer science courses, a bootcamp, or personal projects
- Have built something with AI, even a small personal workflow
Requirements
- 1+ years as an SDR or BDR in B2B SaaS
- A record of hitting or exceeding meeting or pipeline targets
- AI fluency: use AI tools in daily work
- Technical curiosity about APIs, webhooks, and integrations
- Strong writing and communication, especially in cold outreach
- A builder's mindset: thrive in ambiguity and help design the process
Benefits
- Competitive salary
- Meaningful equity
- Medical, Dental & Vision
- HSA
- 401(k) Matching
- Commuter benefits
- Free team lunch
- Flexible PTO
- Paid parental leave
- Compassionate leave
- Team socials and retreats
Company overview
Ampersand Biomedicines is a pioneering biotechnology company founded in 2021 at Flagship Labs, a unit of Flagship Pioneering. The company is dedicated to solving one of the most significant challenges in drug development: creating therapies that act precisely at disease sites without affecting healthy tissues. Ampersand's innovative approach centers on its proprietary Address, Navigate, Determine (AND) Platform, which designs next-generation modular medicines called AND-Body Therapeutics. These programmable biologics combine localizing elements that target specific disease sites with actuator elements that modify disease biology, enabling precise therapeutic action while minimizing off-tissue side effects. The company's technology leverages computational power and multi-omics data to identify unique cell surface features that serve as localizing drug targets. With headquarters in Boston, Massachusetts, Ampersand has secured significant funding including a $65 million Series B round in 2025 from investors including Flagship Pioneering and Eli Lilly. The company focuses on developing treatments across multiple therapeutic areas including immuno-oncology, obesity, and immuno-inflammation, with lead programs advancing toward clinical development.